Open company graph database — free web & API
Login

Teijin Healthcare Inc.

帝人ヘルスケア株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
1,706
Related companies
3
§01

Basic information

BASIC
Head office
3-2-1 Kasumigaseki, Chiyoda-ku, Tokyo 100-8585, Japan (Kasumigaseki Common Gate West Building)
Chief executive
Katsuhiko Yokota
Capital
100,000,000 JPY
Employees (non-consolidated)
1,706 people
Employees (consolidated)
Start date
1994-12-01
End date
§02

Websites

1 DOMAINS
§03

Business

7
Pharmaceutical information provisionHome medical device sales and rentalsProvision of home medical servicesBone and joint productsRehabilitation and neurological productsRespiratory productsMetabolism and circulatory products
§04

Related companies

3 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
スリープメディカルサービス
Group
Teijin Pharma Co., Ltd.
Group
帝人訪問看護ステーション
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

59 EVENTS

Start of exploration within Teijin Ltd. Future Business DivisionSources

Research on oxygen enrichment membrane device at Teijin Ltd.Sources

Pharmaceutical research initiationSources

Development partnership with Bayer Ingelheim GermanySources

Establishment of pharmaceutical business divisionSources

Establishment of biomedical research instituteSources

Establishment of the Iwakuni Manufacturing Plant for the Pharmaceutical Business DivisionSources

Establishment of Teijin Pharma Ltd.Sources

Start of sales partnership with Fujisawa Pharmaceutical Co., Ltd.Sources

Start of direct sales in the Tokyo metropolitan areaSources

Start of home oxygen therapy businessSources

Home oxygen therapy covered by health insuranceSources

Start of direct sales in the Kinki regionSources

Joint development partnership with Merck & Co., Inc. and Banyu Pharmaceutical Co., Ltd. (now MSD Corporation) in the USASources

Establishment of Teijin MRC Research Institute in the UKSources

Start of self-sales in Tokai regionSources

Establishment of Teijin Home Medical Chubu Co., Ltd. and Teijin Home Medical West Japan Co., Ltd.Sources

Establishment of Teijin Home Medical East Japan Co., Ltd., Teijin Home Medical Tokyo Co., Ltd., and Teijin Home Medical Kansai Co., Ltd.Sources

Start of nationwide self-sales of pharmaceuticalsSources

Establishment of Teijin Home Medical Kyushu Co., Ltd.Sources

License agreement with Big Gorden GmbH in Germany (now Takeda GmbH)Sources

License agreement with Tap Holdings Inc. in the U.S. (now Takeda Pharmaceuticals U.S.A., Inc.)Sources

Establishment of visiting nursing stationSources

Establishment of Teijin America, Inc., a pharmaceutical development base in the U.S.Sources

License agreement with Ipsen in FranceSources

Start of operations as Teijin Pharma Co., Ltd.Sources

License agreement with SK Chemical in KoreaSources

Contracted outpatient medical business of Fujisawa Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.)Sources

Establishment of Teijin Home Medical Co., Ltd. through merger of 6 sales companiesSources

Establishment of Yuyu Teijin Medicare Inc., a joint venture with Yuyu Inc. in KoreaSources

Establishment of Sleep Medical Service Co., Ltd.Sources

Business alliance with Dowa Pharmaceutical Co., Ltd. in KoreaSources

Establishment of Estebe Teijin Healthcare, a joint venture with Laboratorios del Doctor Estebe in SpainSources

Sales partnership with Astellas in TaiwanSources

Italy Menarini Company and Sub-License AgreementSources

China Astellas Company, Hong Kong Astellas Company, and Sales PartnershipSources

Astellas Pharma Inc. and Sales PartnershipSources

UK Pulmagen Therapeutics and License AgreementSources

USA Amgen and License AgreementSources

Establishment of Teijin Medical Devices (Shanghai) Co., Ltd. in ChinaSources

Start of WalkAide Rental ServiceSources

UK Sigma Tau Pharmaceuticals (now Leadiant Biosciences, Inc.) and Development & Sales AgreementSources

Establishment of Home Medical Care ICT Promotion DepartmentSources

Taisho Pharmaceutical Co., Ltd. and Sales AgreementSources

USA Merck and License AgreementSources

Germany Merz and Japan-exclusive Development & Sales Agreement for New Botulinum Toxin ProductSources

Start of NeuroStar SalesSources

Reorganization of Pharmaceutical and Home Medical Care BusinessSources

Establishment of New Company for Full-Scale Home-Visit Nursing BusinessSources

China TransCellar and License AgreementSources

Start of Capital and Business Alliance with Mealthy Inc.Sources

Transfer of Sales of Type 2 Diabetes Treatment in Japan, Grant of Intellectual Property Rights, and Asset Transfer for Manufacturing and Sales ApprovalSources

Joint Research and Development Agreement with France Iktos SASSources

License Agreement with Swiss Novartis AG for Development, Manufacturing, and Sales Rights of Self-Developed Small MoleculesSources

Denmark Ascendis Pharma, A/S. and License Agreement for Three Hormone Therapy DrugsSources

Establishing a joint venture with Acelled CorporationSources

France Biporojet and License Agreement for Candidate Compounds for Narcolepsy TreatmentSources

Establishment of a joint venture 'JMS Teijin Home Medical Care Co., Ltd.' developing peritoneal dialysis-related businessSources

The rare disease drug 'TransCon CNP' for achondroplasia in domestic clinical trial preparation has been designated as a rare disease medical product by the Ministry of Health, Labour and WelfareSources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information4010001098723
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
帝人ヘルスケア株式会社
Trade name (kana)
テイジンヘルスケア
Name in English
Corporation type
301
Address
〒100-0013 東京都千代田区霞が関3丁目2番1号
Postal code
1000013
Prefecture code
13
City code
101
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2024-04-09
Change date
2020-04-01
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
11
Correction type
1
Trade name image ID
Address image ID
Sequence number
1720606
METI gBizINFO4010001098723
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
4010001098723
Trade name
帝人ヘルスケア株式会社
Trade name (kana)
テイジンヘルスケア
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都千代田区霞が関3丁目2番1号
Postal code
1000013
Prefecture
東京都
Prefecture code
13
City or district
千代田区
City code
101
Street address
霞が関3丁目2番1号
Organisation type
301
Processing type
11
Correction type
1
Status
Representative
代表取締役 横田 勝彦
Capital
Employees
969
Employees (male)
Employees (female)
Business summary
在宅医療事業、医薬品事業
Website URL
Year founded
Business category
K:不動産業、物品賃貸業
Date established
1994-12-09
Unified government qualification - grade
|A|A|
Unified government qualification - business items
219|222|308
Update date
2024-04-09
Key information
4010001098723
§09

Sources & updates

SOURCES
↑